Bixiye
P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2018
Natiijooyinka Raadinta
Soo bandhiga 3111 - 3120 ee natiijooyinka 4130
Bixiye
P35-17 Addition of Drug to the Substance Reduction Therapy Prior Authorization with Quantity Limit Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2017
Bixiye
P49-17 Two New Medicare Advantage Prescription Drug Products in 2018
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 25, 2017
Bixiye
P11-17 Pre-Admission Notification Requirement for Admissions Effective June 1, 2017
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 04, 2017
Bixiye
P76-17 Centurion moving to Blue Cross for Claims Administration Services
Taariikhda uu dhaqangalayo Barnaamijka: Des 07, 2017
Bixiye
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Taariikhda uu dhaqangalayo Barnaamijka: Jan 09, 2018
Bixiye
2018 May Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P25-17 Addition of New Drugs to the Hepatitis C Second Generation Antivirals Prior Authorization (PA) with Quantity Limit (QL) Program
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P32-17 Minnesota Senior Health Options Model of Care Requirements
Taariikhda wax ku ool ah ee barnaamijka: Jun 12, 2017
Bixiye
P72-17 New Availity Functionality Available to Create and Submit an Electronic Referral
Taariikhda uu dhaqangalayo Barnaamijka: Nov 17, 2017